Product NDC: | 53346-1201 |
Proprietary Name: | DR RECKEWEG BC-1 |
Non Proprietary Name: | CALCAREA PHOSPHORICA, FERRUM PHOSPHORICUM, KALI PHOSPHORICUM, NATRUM MURIATICUM |
Active Ingredient(s): | 3; 3; 6; 3 [hp_X]/20g; [hp_X]/20g; [hp_X]/20g; [hp_X]/20g & nbsp; CALCAREA PHOSPHORICA, FERRUM PHOSPHORICUM, KALI PHOSPHORICUM, NATRUM MURIATICUM |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 53346-1201 |
Labeler Name: | PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED HOMEOPATHIC |
Start Marketing Date: | 20120101 |
Package NDC: | 53346-1201-2 |
Package Description: | 20 g in 1 BOTTLE (53346-1201-2) |
NDC Code | 53346-1201-2 |
Proprietary Name | DR RECKEWEG BC-1 |
Package Description | 20 g in 1 BOTTLE (53346-1201-2) |
Product NDC | 53346-1201 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | CALCAREA PHOSPHORICA, FERRUM PHOSPHORICUM, KALI PHOSPHORICUM, NATRUM MURIATICUM |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20120101 |
Marketing Category Name | UNAPPROVED HOMEOPATHIC |
Labeler Name | PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO |
Substance Name | FERROSOFERRIC PHOSPHATE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE; TRIBASIC CALCIUM PHOSPHATE |
Strength Number | 3; 3; 6; 3 |
Strength Unit | [hp_X]/20g; [hp_X]/20g; [hp_X]/20g; [hp_X]/20g |
Pharmaceutical Classes |